Conditions: Dry Eye Syndrome
Keywords: Dry Eye Syndrome Recent Diagnosis of Dry Eye Syndrome
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 27
Healthy volunteers: no

Brief summary:
The investigators hypothesize that oral omega-3-acid ethyl esters (Lovaza, GlaxoSmithKline, Research Triangle Park, NC) will decrease dry-eye related symptoms as well as clinical markers associated with dry eye disease (Schirmer-1 test values, positive vital staining with lissamine green, and fluorescein tear break-up time) when compared to administration of placebo.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Oral Omega-3-acid ethyl esters intervention 2: Placebo corn oil capsule
Intervention descriptions: intervention 1: 1 gram capsule by mouth four times daily for 45 days intervention 2: 1 gram by mouth 4 times daily for 45 days

Protocol document: